z-logo
open-access-imgOpen Access
Differential Responsiveness to Interferon-α in β-Cells and Non-β-Cells
Author(s) -
V. BonnevieNielsen,
Karsten Buschard,
Thomas Dyrberg
Publication year - 1996
Publication title -
diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.219
H-Index - 330
eISSN - 1939-327X
pISSN - 0012-1797
DOI - 10.2337/diab.45.6.818
Subject(s) - insulitis , beta (programming language) , biology , alpha (finance) , cytokine , interferon , alpha interferon , immune system , microbiology and biotechnology , interferon gamma , immunology , autoimmunity , medicine , computer science , nursing , patient satisfaction , programming language , construct validity
Interferon-α (IFN-α) is important in the innate immune defense, particularly in viral infections. IFN-α induces 2ʹ,5ʹA synthetase, the products of which, 2ʹ,5ʹ-oligoadenine nucleotides, activate mRNA degrading enzymes. IFN-α is the first detectable cytokine in the insulitis lesion seen in recent-onset IDDM, and insulin promoter directed expression of IFN-α in transgenic mice leads to development of IDDM. Here, we demonstrate that IFN-α induces 2ʹ,5ʹA synthetase activity only in insulin-producing βTC3 cells and in isolated single rat β-cells but not in αTC3 cells or in isolated rat non-β-cells. The increased responsiveness of β-cells but not non-β-cells to IFN-α with the ensuing activation of the mRNA-degrading 2ʹ,5ʹA synthetase system suggests why only the β-cells are destroyed in the diabetogenic process.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom